Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
The Journal of Liquid Biopsy|March 3, 2025
Early monitoring of plasma KRAS G12C with digital PCR predicts antitumor response to immunotherapy or sotorasib in advanced NSCLC: A brief reportAndrea De Giglio, Federico Zacchini, Giulia Venturi, et al.
Lung Cancer (Amsterdam, Netherlands)|December 22, 2024
STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 statusAndrea De Giglio, Dario De Biase, Valentina Favorito, et al.
Clinical Lung Cancer|April 12, 2020
Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective StudyRoberta Minari, Giulia Mazzaschi, Paola Bordi, et al.
The Journal of Liquid Biopsy|March 3, 2025
Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experienceClaudia Parisi, José Carlos Benitez, Hélène Lecourt, et al.
Current Oncology Reports|July 27, 2024
Exploring the Role of Target Expression in Treatment Efficacy of Antibody-Drug Conjugates (ADCs) in Solid Cancers: A Comprehensive ReviewLaurent Mathiot, Capucine Baldini, Octave Letissier, et al.
New Biotechnology|July 6, 2020
Development of a bioeconomy monitoring framework for the European Union: An integrative and collaborative approachNicolas Robert, Jacopo Giuntoli, Rita Araujo, et al.
Critical Reviews in Oncology/Hematology|November 25, 2023
Antibody drug conjugates in older patients: State of the artLayal Rached, Arthur Geraud, Maxime Frelaut, et al.
Frontiers in Oncology|May 29, 2026
Predicting survival of patients treated with antibody-drug conjugates in early-phase clinical trials using AI-quantified 3D body composition on CT scansMatthieu Delaye, Littisha Lawrance, Younes Belkouchi, et al.
The Lancet. Oncology|July 3, 2026
Differential impact of proton pump inhibitors and antibiotics on immunotherapy efficacy after chemoradiotherapy in locally advanced non-small-cell lung cancer: a post-hoc analysis of the PACIFIC trialLeonardo Brunetti, Valentina Santo, David J Pinato, et al.
Nature Communications|November 19, 2021
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damagePietro Carotenuto, Francesco Amato, Andrea Lampis, et al.
Pageof 6